HPV: Humans papillomavirus Cancer Affect Males Not Only Women

by Archynetys Health Desk

HPV Vaccination: A Critical Step in Preventing Cancer for All Genders

The European Institute of Oncology (IEO) in Milan has launched a powerful call to action: HPV (Human Papillomavirus) cancer is not just a women’s issue. Both men and women are affected by HPV-related cancers, and the prevalence among men has been increasing steadily. As we move closer to the World Day against HPV on March 4th, the IEO underscores the urgent need for a vaccination strategy that encompasses both sexes.

The Increasing Threat of HPV-Related Cancers

Oropharyngeal tumors, particularly those linked to HPV, have more than doubled in the last 30 years, primarily affecting males. Experts at the IRCCS IEO, founded by Umberto Veronesi, warn that these tumors could surpass prostate cancer in incidence in the coming decade. The rise in HPV-related cancers extends beyond oropharyngeal tumors, making comprehensive vaccination a critical necessity.

The Case for No-Gender Vaccination

Stefano Filippo Zorzi, a specialist in cervical-facial surgery at the IEO, emphasizes that worldwide, about 5% of all cancer cases are linked to HPV. This sexually transmitted infection affects nearly 625,000 women and 69,400 men annually. Zorzi’s editorial in the ‘European Journal of Cancer Prevention’ highlights the crucial role of vaccination in diminishing the spread of this virus and reducing the incidence of related cancers.

Broad-Spectrum Vaccination: The Key to Prevention

The IEO experts advocate for maximum vaccination coverage, ideally starting at 12 years of age, before any type of sexual activity. While protective effectiveness is maintained even in adulthood, early vaccination ensures broader protection. The vaccine is part of the National Health Service, with different regions extending its free administration to broader age groups, including co-pay options in some areas.

Case Study: The IEO’s Leadership in HPV Awareness and Vaccination

The IEO has been at the forefront of HPV awareness and prevention, positioning itself as a regional vaccination center. It is one of the first institutions in Italy to offer the non-avalent vaccine, which protects against all prevalent carcinogenic variants of the virus, effectively preventing over 90% of associated cancers.

Future Trends in HPV Vaccination

Based on current data and expert predictions, the following trends are likely to shape the future of HPV vaccination and cancer prevention:

| Trend | Description |
|——-|————-|
| **Expanded Vaccination Age Range** | More regions are expected to extend free vaccination to older age groups, increasing overall coverage. |
| **Advanced Vaccine Technology** | The development of even more effective and broader-spectrum vaccines will continue to improve preventive measures. |
| **Increased Awareness Campaigns** | Public awareness and educational campaigns will likely intensify, aimed at both genders to promote vaccination uptake. |
| **Global Vaccination Initiatives** | International efforts to standardize HPV vaccination policies will likely increase, focusing on low- to middle-income countries where HPV incidence is higher. |
| **Health Policy Shifts** | More regions and countries are expected to integrate HPV vaccination as a standard part of their National Health Service, making it more accessible and affordable. |

Pro Tips for Parents and Individuals

  • Ensure your children receive the HPV vaccine at the recommended age of 12, or as early as possible before sexual activity.
  • Stay informed about local vaccination policies and eligibility criteria for free or co-paid vaccination.
  • Support community and public awareness campaigns to encourage broader vaccination uptake.
  • Frequently Asked Questions (FAQ)

    Who should get the HPV vaccine?

    Both boys and girls should get the HPV vaccine. The ideal age is at 12 or before any sexual activity commences to ensure maximum protection.

    Is the HPV vaccine effective in adulthood?

    Yes, the HPV vaccine is effective even when administered in adulthood. While earlier vaccination is optimal, it still provides substantial protection against HPV-related cancers.

    How do I find out about vaccination eligibility in my region?

    Contact your local health authorities or consult with a healthcare provider to understand the vaccination policies and eligibility criteria in your area.

    Can the HPV vaccine completely prevent all HPV-related cancers?

    The HPV vaccine is highly effective and can prevent over 90% of related cancers. However, while it significantly reduces the risk, it does not guarantee absolute protection against all HPV-related cancers.

    Did you know?

    The IEO is among the first entities in Italy to offer the non-avalent vaccine, providing comprehensive protection against all main carcinogenic variants of the HPV virus.

    What’s Next?

    Join the conversation on our social media channels, and stay updated on the latest in HPV prevention and cancer awareness. Subscribe to our newsletter to receive timely and relevant information directly to your inbox.

    Reflections like these are the foundation of our continuous efforts to improve the landscape of cancer prevention. Be part of this decisive movement.

    Important trends to consider are as follows:

    Did you read the New Articles Focusing on:

     

    Related Posts

    Leave a Comment